PHARMA STAN 50 (Stanozolol) from Pharmacom Labs is an aqueous suspension of fine stanozolol particles. Currently, it is the most micronized aqueous stanozolol suspension on the market, allowing the use of any type of needle and various injection sites for intramuscular injections. The injectable aqueous stanozolol suspension exhibits unusual pharmacokinetics, with a longer-lasting effect that gradually diminishes. Individual stanozolol particles can remain at the injection site for extended periods, and the duration of activity likely extends for at least one week. As a DHT derivative, stanozolol cannot aromatize into estrogens. Therefore, stanozolol does not cause water retention; it may even have a diuretic effect. This makes it an excellent steroid for use during cutting cycles to reduce excess water and fat, as well as whenever the main goal is to achieve defined and hard musculature. Stanozolol's ability to promote strength and muscle growth without water retention makes it highly valued by dieting bodybuilders and competitive athletes in strength and speed sports.
WARNING: Stanozolol is known for its ability to dry out synovial fluid, which can lead to joint pain and damage. Do not train with maximum loads while taking stanozolol. Combining testosterone with stanozolol may help alleviate this effect by retaining some water. Additionally, stanozolol can cause adverse changes in the lipid profile. Cholesterol levels (HDL and LDL) should be kept under control during the cycle. Due to its C17-alpha alkylation, stanozolol can overload the liver. The recommended duration of a stanozolol cycle should not exceed 6 to 8 weeks.
WARNING: This product is not an oil, but an aqueous suspension . To avoid complications, do not use it mixed with oil-based products in the same syringe!
Chemical name 17α-Methyl-17β-hydroxy-[5α]-androst-2-ene[3,2-c]pyrazole
Formula C21H32N2O
Anabolic activity index 320%
androgenic activity index 30%
PHARMA STAN 50 (Stanozolol) from Pharmacom Labs is an aqueous suspension of fine stanozolol particles. Currently, it is the most micronized aqueous stanozolol suspension on the market, allowing the use of any type of needle and various injection sites for intramuscular injections. The injectable aqueous stanozolol suspension exhibits unusual pharmacokinetics, with a longer-lasting effect that gradually diminishes. Individual stanozolol particles can remain at the injection site for extended periods, and the duration of activity likely extends for at least one week. As a DHT derivative, stanozolol cannot aromatize into estrogens. Therefore, stanozolol does not cause water retention; it may even have a diuretic effect. This makes it an excellent steroid for use during cutting cycles to reduce excess water and fat, as well as whenever the main goal is to achieve defined and hard musculature. Stanozolol's ability to promote strength and muscle growth without water retention makes it highly valued by dieting bodybuilders and competitive athletes in strength and speed sports.
WARNING: Stanozolol is known for its ability to dry out synovial fluid, which can lead to joint pain and damage. Do not train with maximum loads while taking stanozolol. Combining testosterone with stanozolol may help alleviate this effect by retaining some water. Additionally, stanozolol can cause adverse changes in the lipid profile. Cholesterol levels (HDL and LDL) should be kept under control during the cycle. Due to its C17-alpha alkylation, stanozolol can overload the liver. The recommended duration of a stanozolol cycle should not exceed 6 to 8 weeks.
WARNING: This product is not an oil, but an aqueous suspension . To avoid complications, do not use it mixed with oil-based products in the same syringe!
Chemical name 17α-Methyl-17β-hydroxy-[5α]-androst-2-ene[3,2-c]pyrazole
Formula C21H32N2O
Anabolic activity index 320%
androgenic activity index 30%